NICE has developed a medtech innovation briefing (MIB) on FreeStyle Libre for glucose monitoring.

At the of time of publication, no NHS price for FreeStyle Libre was available. NICE plans to update this MIB when there is further relevant information.

January 2019: The Medicines and Healthcare products Regulatory Agency issued a medical device alert for FreeStyle Libre. Users might apply creams, patches or sprays under their sensor to reduce skin reactions. This could affect device performance.

This MIB was updated in September 2017 to reflect new NICE recommendations on ketone testing.

What are MIBs?